Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study
CONCLUSIONS: Patients with D2T RA had high clinical and ultrasound activity and poor responses to treatment with b/tsDMARDs. CTLA4-Ig was associated with a good response at 12 months in D2T RA patients.PMID:38085537 | DOI:10.1080/03009742.2023.2277542 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - December 12, 2023 Category: Rheumatology Authors: T Michitsuji S Fukui S Morimoto Y Endo A Nishino S Nishihata Y Tsuji T Shimizu M Umeda R Sumiyoshi T Koga N Iwamoto T Origuchi Y Ueki T Yoshitama N Eiraku N Matsuoka A Okada K Fujikawa H Ohtsubo H Takaoka H Hamada T Tsuru M Nawata Y Arinobu T Hidaka Y Tad Source Type: research

Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis
Scand J Rheumatol. 2023 Dec 12:1-3. doi: 10.1080/03009742.2023.2286118. Online ahead of print.NO ABSTRACTPMID:38085533 | DOI:10.1080/03009742.2023.2286118 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - December 12, 2023 Category: Rheumatology Authors: M Guerini D Sorace F Bobbio Pallavicini V Codullo M Lucioni S Fraticelli J Vigan ò P Quaretti P Delvino Source Type: research

Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study
CONCLUSIONS: Patients with D2T RA had high clinical and ultrasound activity and poor responses to treatment with b/tsDMARDs. CTLA4-Ig was associated with a good response at 12 months in D2T RA patients.PMID:38085537 | DOI:10.1080/03009742.2023.2277542 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - December 12, 2023 Category: Rheumatology Authors: T Michitsuji S Fukui S Morimoto Y Endo A Nishino S Nishihata Y Tsuji T Shimizu M Umeda R Sumiyoshi T Koga N Iwamoto T Origuchi Y Ueki T Yoshitama N Eiraku N Matsuoka A Okada K Fujikawa H Ohtsubo H Takaoka H Hamada T Tsuru M Nawata Y Arinobu T Hidaka Y Tad Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research

Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment
Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707. Online ahead of print.NO ABSTRACTPMID:38031721 | DOI:10.1080/03009742.2023.2274707 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: T Komai T Sawada H Tsuchiya H Harada H Shoda K Fujio Source Type: research

Thiemann's disease: a very rare bone disorder
Scand J Rheumatol. 2023 Nov 30:1-2. doi: 10.1080/03009742.2023.2274657. Online ahead of print.NO ABSTRACTPMID:38031722 | DOI:10.1080/03009742.2023.2274657 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: D Bulut G ökten R Mercan Source Type: research

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
CONCLUSIONS: A substantial proportion of PsA patients reported unacceptable pain throughout the first anti-TNF treatment year. At 12 months, refractory pain constituted about two-thirds of this remaining pain load. More objective signs of inflammation at anti-TNF initiation were associated with less future refractory pain. This highlights insufficient effect of biologics in patients with inflammation-independent pain, warranting alternative treatments.PMID:38031733 | DOI:10.1080/03009742.2023.2258644 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - November 30, 2023 Category: Rheumatology Authors: C Roseman J K Wallman A J öud Mec Schelin J T Einarsson E Lindqvist J Lampa M C Kapetanovic T Olofsson Source Type: research